These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 31279635)

  • 1. Multimodal neuroimaging relationships in progressive supranuclear palsy.
    Sintini I; Schwarz CG; Senjem ML; Reid RI; Botha H; Ali F; Ahlskog JE; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
    Parkinsonism Relat Disord; 2019 Sep; 66():56-61. PubMed ID: 31279635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroimaging correlates of gait abnormalities in progressive supranuclear palsy.
    Sintini I; Kaufman K; Botha H; Martin PR; Loushin SR; Senjem ML; Reid RI; Schwarz CG; Jack CR; Lowe VJ; Josephs KA; Whitwell JL; Ali F
    Neuroimage Clin; 2021; 32():102850. PubMed ID: 34655905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants.
    Whitwell JL; Tosakulwong N; Botha H; Ali F; Clark HM; Duffy JR; Utianski RL; Stevens CA; Weigand SD; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Ahlskog JE; Dickson DW; Josephs KA
    Neuroimage Clin; 2020; 25():102152. PubMed ID: 31935638
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Nicastro N; Rodriguez PV; Malpetti M; Bevan-Jones WR; Simon Jones P; Passamonti L; Aigbirhio FI; O'Brien JT; Rowe JB
    J Neurol; 2020 Feb; 267(2):341-349. PubMed ID: 31641878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and neuroimaging characteristics of primary lateral sclerosis with overlapping features of progressive supranuclear palsy.
    Badihian N; Gatto RG; Satoh R; Ali F; Clark HM; Pham NTT; Whitwell JL; Josephs KA
    Eur J Neurol; 2024 Aug; 31(8):e16320. PubMed ID: 38686979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal cross-examination of progressive apraxia of speech by diffusion tensor imaging-based tractography and Tau-PET scans.
    Gatto RG; Pham NTT; Duffy JR; Clark HM; Utianski RL; Botha H; Machulda MM; Lowe VJ; Schwarz CG; Jack CR; Josephs KA; Whitwell JL
    Hum Brain Mapp; 2024 Jun; 45(8):e26704. PubMed ID: 38825988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional multimodal relationships between tau, hypometabolism, atrophy, and fractional anisotropy in atypical Alzheimer's disease.
    Sintini I; Schwarz CG; Martin PR; Graff-Radford J; Machulda MM; Senjem ML; Reid RI; Spychalla AJ; Drubach DA; Lowe VJ; Jack CR; Josephs KA; Whitwell JL
    Hum Brain Mapp; 2019 Apr; 40(5):1618-1631. PubMed ID: 30549156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Fully Automated, Atlas-Based Approach for Superior Cerebellar Peduncle Evaluation in Progressive Supranuclear Palsy Phenotypes.
    Nicoletti G; Caligiuri ME; Cherubini A; Morelli M; Novellino F; Arabia G; Salsone M; Quattrone A
    AJNR Am J Neuroradiol; 2017 Mar; 38(3):523-530. PubMed ID: 28034996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion tensor imaging of Parkinson's disease, multiple system atrophy and progressive supranuclear palsy: a tract-based spatial statistics study.
    Worker A; Blain C; Jarosz J; Chaudhuri KR; Barker GJ; Williams SC; Brown RG; Leigh PN; Dell'Acqua F; Simmons A
    PLoS One; 2014; 9(11):e112638. PubMed ID: 25405990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral Tau Deposition in Comorbid Progressive Supranuclear Palsy and Amyotrophic Lateral Sclerosis: An [18F]-Flortaucipir and 7T MRI Study.
    Cheong I; Du Y; Smith G; Hua J; Li X; Pantelyat A
    Neurodegener Dis; 2023; 23(3-4):35-42. PubMed ID: 38527450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy.
    Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Steiger R; Wildauer M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
    Parkinsonism Relat Disord; 2018 Apr; 49():81-87. PubMed ID: 29463454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Track density imaging: A reliable method to assess white matter changes in Progressive Supranuclear Palsy with predominant parkinsonism.
    Nigro S; Barbagallo G; Bianco MG; Morelli M; Arabia G; Quattrone A; Gasparini S; Cascini GL; Quattrone A
    Parkinsonism Relat Disord; 2019 Dec; 69():23-29. PubMed ID: 31665684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroimaging comparison of primary progressive apraxia of speech and progressive supranuclear palsy.
    Whitwell JL; Duffy JR; Strand EA; Machulda MM; Senjem ML; Gunter JL; Kantarci K; Eggers SD; Jack CR; Josephs KA
    Eur J Neurol; 2013 Apr; 20(4):629-37. PubMed ID: 23078273
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Schonhaut DR; McMillan CT; Spina S; Dickerson BC; Siderowf A; Devous MD; Tsai R; Winer J; Russell DS; Litvan I; Roberson ED; Seeley WW; Grinberg LT; Kramer JH; Miller BL; Pressman P; Nasrallah I; Baker SL; Gomperts SN; Johnson KA; Grossman M; Jagust WJ; Boxer AL; Rabinovici GD
    Ann Neurol; 2017 Oct; 82(4):622-634. PubMed ID: 28980714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct comparison between
    Satoh R; Ali F; Botha H; Lowe VJ; Josephs KA; Whitwell JL
    Neuroimage; 2024 Feb; 286():120509. PubMed ID: 38184157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion tensor imaging comparison of progressive supranuclear palsy and corticobasal syndromes.
    Whitwell JL; Schwarz CG; Reid RI; Kantarci K; Jack CR; Josephs KA
    Parkinsonism Relat Disord; 2014 May; 20(5):493-8. PubMed ID: 24656943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of Microstructural Degeneration in Progressive Supranuclear Palsy and Corticobasal Syndrome: A Longitudinal Diffusion Tensor Imaging Study.
    Zhang Y; Walter R; Ng P; Luong PN; Dutt S; Heuer H; Rojas-Rodriguez JC; Tsai R; Litvan I; Dickerson BC; Tartaglia MC; Rabinovici G; Miller BL; Rosen HJ; Schuff N; Boxer AL
    PLoS One; 2016; 11(6):e0157218. PubMed ID: 27310132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic tau lesions and magnetic resonance imaging biomarkers differ across two progressive supranuclear palsy variants.
    Orlandi F; Carlos AF; Ali F; Clark HM; Duffy JR; Utianski RL; Botha H; Machulda MM; Stephens YC; Schwarz CG; Senjem ML; Jack CR; Agosta F; Filippi M; Dickson DW; Josephs KA; Whitwell JL
    Brain Commun; 2024; 6(2):fcae113. PubMed ID: 38660629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Potential of Multimodal MRI Markers in Atypical Parkinsonian Disorders.
    Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Kremser C; Wildauer M; Schocke M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
    J Parkinsons Dis; 2019; 9(4):681-691. PubMed ID: 31450511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced structural neuroimaging in progressive supranuclear palsy: Where do we stand?
    Stezin A; Lenka A; Jhunjhunwala K; Saini J; Pal PK
    Parkinsonism Relat Disord; 2017 Mar; 36():19-32. PubMed ID: 28057431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.